Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CRVS:When CD73 Antibody was Added to AZN's IMFINZI.the Decline in the Risk of Desease Progression or Death Stood @ 56% Compared to Only 35% with MONALIZUMAD-made by AZN/IPHA.
AZN Needs CRVS,s CD73 Antobody-Called MUPADOLIMAB-to Improve Patients Rresults from 35% to 56%-thus a Big Deal and brings CRVS's CD73 Asset Value to at Least $1B Mkt Cap.
Conference Call Nextweek
Angel Pharma Update
56% Tutes Holdings
Insider Buying
PPS To Double Digits cometh,jmhtto
Green with another High Trade Volume
Lol maybe not
I know I sold at 4.40
All out 4.50's, hod 4.87? Crazy! See how it goes into close and next week.
AZN..Results from the large, randomized COAST Phase II trial showed oleclumab, an anti-CD73 monoclonal antibody, or monalizumab, an anti-NKG2A monoclonal antibody, in combination with IMFINZI® (durvalumab) improved progression-free survival (PFS) and objective response rate (ORR) compared to IMFINZI alone in patients with unresectable, Stage III non-small cell lung cancer (NSCLC) who had not progressed after concurrent chemoradiation therapy (CRT).
At an appointment, missed the 4.40's! Bummer!
Volume is almost... tripled the OS
I saw the form 4's for their free options, you know they'll be taking advantage. Though that's just my guess. Locked in the green but still like this for long. I'll be adding back in.
Typical Pump in Premarket then sell off after 15 minutes in regular hours.
I've been selling, still have a few left to see what happens. Not seeing anything news wise. Even comes close to filling the gap I'll be adding back in big time!!
48 hours ago, one-on-one meetings with investors at Wainwright conference, and a pre-recorded corporate overview presentation by Richard A. Miller, M.D., president and chief executive officer of Corvus.
Investors & tutes accumulating shares.
May have to do with Triple Witching??..
SEC filing..Stock options..right to buy..from 9-13..no news yesterday or today..
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the Company's management will participate in two upcoming investor conferences in September:
-- The first conference is the H.C. Wainwright Annual Global Investment Conference, which is taking place September 13-15, 2021. The Company will conduct one-on-one meetings with investors at this conference and a pre-recorded corporate overview presentation by Richard A. Miller, M.D., president and chief executive officer of Corvus, will be available to play on-demand starting at 7:00 am ET on September 13. Attendees can register to view the webcast here.
-- The second conference is the Cantor Virtual Global Healthcare Conference, which is taking place September 27-30, 2021. The Company will conduct one-on-one meetings with investors at this conference and a virtual corporate overview presentation will be conducted by Dr. Miller at 3:20-3:50 pm ET on September 29. Attendees can register for the virtual presentation here.
Attendees can also access the webcast of the presentations noted above via the investor relations section of the Corvus website and replays will be available for 90 days following the events.
CRVS up 59% on recent SEC filings > Form 4.
Pre-market high 3.94 now $CRVS up over 50% in the 3.50's pre market after form 4 action filed on the 13th.
Not sure why else so far but who passes a 60% gain? Not me. Riding free on a chunk to see what happens. Volume suggests something is going on.
Apparently TDameritrade doesn't start trading till 7 am???? BS. Might have to find myself a new home.
Form 4 statement...
Explanation of Responses:
(1) The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from September 9, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
https://ih.advfn.com/stock-market/NASDAQ/corvus-pharmaceuticals-CRVS/stock-news/86039905/statement-of-changes-in-beneficial-ownership-4
Nice push! I remember the old days when "Happy Hour" was really a thing in the last hour of trading!
$CRVS!
Just waiting on news now. This stock has huge potential.
I took a position today at 3.65. We shall see where it goes from here.
I was thinking about hopping in here also. The price just seems to good.
took a position here at 3.85. Watching to see if this has any action.
* * $CRVS Video Chart 10-05-2020 * *
Link to Video - click here to watch the technical chart video
Doesn’t matter. Stock dud today.
Either institutional selling or shorts attacking stock.
Maybe financing in the works which is typical for these biotech runners.
David.
My bad. Wrong stock.
Sorry.
Too early for me to think straight.
Lol.
David.
What is the call about?
Good news today.
Never know how these will respond to news.
Watching.
David.
Take it. sorry u need it. Haha. not much care here, sad display. Venus flytrap. Happy to have left on an up day, as prescribed. Eyes!
One couldn't move this stock with a plow. Giddy up. Knew you guys were Robots.
Someone either feed this dog or shoot it, imo. Could not get a bead on when the financials were to be provided, it seems EOD, if not, these guys really suck, imo. Anyone, Anyone, Bueller? Lol.
Interesting tactic to erode away share price the 2nd 1/2 of the month. Wonderful, and the report on Thursday...
Looking forward to Thursday. Perhaps if the market on the whole this week, we see an increase in sp.
Welcome to the board. Pretty tight-lipped around here. A very responsible board making the individuals do their own DD. Imo.
I’m a new investor in Corvus. I like the looks of it. Bought on a dip today.
Any predictions for the upcoming week as we head to the phone call on Thursday?
FDA rumors? Pipeline rumors? Phase 1-3 rumors?
Analysts seem high on this company. Just takes patience
Perhaps after their reporting on 7/30, one may feel comfortable enough to engage in some speculation? Haha. Hopefully i didn't run everyone off permanently, not my intention. Guessing all here are Cali insiders. I do hope they grow back at some point. Lol.
I didn't anticipate this is a tortuous race! Gezzz. Glad i have horses in other races too. This must be embarrassing for management with all of the innovation going on around them. Hope they get some traction, and soon. Jmo.
Wtf! This stupid ticker can't even get out of its own way. Just goes to show you can research and find DD, and it doesn't make a schitts bit of difference on some of this bullshit tickers that a few weeks ago had positive potential, now only downward pressure. Lame.
Looking forward to see if this can get some footing this week. Hard to believe, in this environment, they aren't working harder to get things moving.
Starting to think this board is merely a board of Robots. No information exchange or speculation. Not on many boards, but this is the most introverted board i have experienced to date. Hope at least there are PM's flying around. Haha. Perhaps im the bag holder, and everyone sold out when i was buying in. I bark, but rarely bite.
Followers
|
24
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
257
|
Created
|
04/04/17
|
Type
|
Free
|
Moderators |
July 7, 2020 09:36 AM ET (BZ Newswire) -- News
Shares of Corvus Pharmaceuticals Inc (NASDAQ:CRVS) are "" rel="nofollow ugc" target="_blank">https://www.benzinga.com/pre-market-outlook/20/07/16530313/18-healthcare-stocks-moving-in-tuesdays-pre-market-session"; rel="nofollow ugc">advancing strongly Tuesday following an announcement concerning its foray into COVID-19 treatment.
The company expects to report data from the study later this year.
Shares were rallying 85.04% to $5.07
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |